180 Life Sciences Files 8-K on Common Stock and Warrants
Ticker: FRMM · Form: 8-K · Filed: Feb 20, 2024 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K |
| Filed Date | Feb 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $3 million, $2 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, equity-structure
TL;DR
**180 Life Sciences just filed an 8-K, confirming their common stock par value and warrants, but no major news.**
AI Summary
180 Life Sciences Corp. filed an 8-K on February 20, 2024, reporting an "Other Event." The filing indicates the company's common stock has a par value of $0.0001 per share and also mentions warrants to purchase shares of common stock. The company, incorporated in Delaware, has its principal executive offices in Palo Alto, CA.
Why It Matters
This filing provides basic structural information about 180 Life Sciences Corp.'s equity, which is fundamental for investors to understand the company's capital structure.
Risk Assessment
Risk Level: low — The filing is purely informational regarding basic company structure and does not indicate any new risks or significant events.
Key Numbers
- $0.0001 — Common Stock Par Value (per share)
Key Players & Entities
- 180 Life Sciences Corp. (company) — Registrant
- Delaware (company) — State of Incorporation
- Palo Alto, CA (company) — Principal Executive Offices
- $0.0001 (dollar_amount) — Common Stock Par Value
- February 20, 2024 (date) — Date of Report
FAQ
What is the par value of 180 Life Sciences Corp.'s common stock?
The common stock of 180 Life Sciences Corp. has a par value of $0.0001 per share, as stated in the filing.
What type of event did 180 Life Sciences Corp. report in this 8-K filing?
180 Life Sciences Corp. reported an "Other Event" in this 8-K filing.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on February 20, 2024.
Where are the principal executive offices of 180 Life Sciences Corp. located?
The principal executive offices of 180 Life Sciences Corp. are located at 3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA 94306.
Does the filing mention any other types of securities besides common stock?
Yes, the filing also mentions "Warrants To Purchase Shares Of Common Stock."
Filing Stats: 706 words · 3 min read · ~2 pages · Grade level 10.8 · Accepted 2024-02-20 08:01:20
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share ATNF The NASDAQ Stock Mar
- $3 million — AmTrust insurance policy has a limit of $3 million and the Freedom insurance policy has a
- $2 million — Freedom insurance policy has a limit of $2 million. It is unclear whether the defendants
Filing Documents
- ea193909-8k_180life.htm (8-K) — 30KB
- 0001213900-24-015102.txt ( ) — 244KB
- atnf-20240220.xsd (EX-101.SCH) — 4KB
- atnf-20240220_def.xml (EX-101.DEF) — 26KB
- atnf-20240220_lab.xml (EX-101.LAB) — 36KB
- atnf-20240220_pre.xml (EX-101.PRE) — 25KB
- ea193909-8k_180life_htm.xml (XML) — 6KB
01. Other Events
Item 8.01. Other Events. On February 12, 2024, the judge in 180 Life Sciences Corp.'s (the " Company's ") pending lawsuit in the U.S. District Court Northern District of California, San Jose Division, granted a Motion for Partial Summary Judgment against AmTrust International Underwriters DAC (" AmTrust "), which was the premerger directors' and officers' insurance policy underwriter for the Company and the Company's excess insurance carrier, Freedom Specialty Insurance Company (" Freedom "), and ordered as follows: (a) AmTrust is obligated under its insurance policy with the Company to advance to the Company all defense costs in excess of the deductible that the Company has advanced or will advance to Dr. Marlene Krauss, the Company's former Chief Executive Officer and Director, and George Hornig, the former Chairman of the Board of Directors, in connection with certain subpoenas issued by the Securities and Exchange Commission; and (b) upon exhaustion of the AmTrust insurance policy, Freedom is obligated to do the same pursuant to its excess liability insurance policy with the Company. This Order applies until the final disposition of the case, but does not constitute a final judgment, and both the Company and the two insurers retain their rights to contest all applicable issues at trial, which is scheduled for May 12, 2025. The AmTrust insurance policy has a limit of $3 million and the Freedom insurance policy has a limit of $2 million. It is unclear whether the defendants will take steps to appeal this order, the outcome of any such appeal, the timing of our receipt of any funds we may receive pursuant to the order related to reimbursement of amounts related to the Securities and Commission subpoenas, if any, or such amounts that we may ultimately receive. A final judgment following trial could potentially confirm these obligations of the insurers or, alternatively, reverse and require the Company to repay all or certain portions of such advance payments
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 180 LIFE SCIENCES CORP. Date: February 20, 2024 By: /s/ James N. Woody, M.D., Ph.D. James N. Woody, M.D., Ph.D. Chief Executive Officer 2